Filter
1653
Text search:
national
drug
authority
Featured
131
542
Language
Document type
974
240
225
95
66
20
18
8
2
2
1
1
Countries / Regions
99
80
71
67
49
47
44
44
42
42
36
35
34
33
32
31
26
24
24
22
19
18
18
17
15
13
12
10
9
9
9
8
8
8
7
6
6
6
5
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
847
87
67
64
48
30
24
Toolboxes
132
119
107
106
63
62
38
35
27
26
26
23
23
23
20
19
19
16
10
9
9
8
8
7
2
EU and Global Governance for Health - How EU global policies impact health
Ethiopia Antimicrobial Resistance Surveillance Plan
WHO/UNICEF/UNFPA joint statement
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
The MSF qualification scheme is concerned with the pharmaceutical quality assessment for drugs. This procedure is applicable to products for international supply, i.e. products supplied through the MSF procurement centres. This qualification procedure is not applicable for local purchase, i.e. purch
...
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul
...
This field study to assess the pharmaceutical situation was undertaken in Ghana in May-June 2008 using a standardized methodology developed by the World Health Organization. The study assessed medicines availability and affordability, geographical accessibility, quality and r
...
